NASHVILLE, Tenn., June 30, 2020 /PRNewswire-PRWeb/ — EvidenceCare, a leading provider of advanced clinical decision support (CDS) technology, today announced the launch of its innovative Admission Criteria solution expanding the company’s CDS platform to create real impact on the hospital revenue cycle by ensuring accurate admission documentation to proactively address a significant source of denials. The company is also announcing the addition of Carol Howard as vice president of clinical content, an industry expert on the clinical aspects of the revenue cycle.
The Admission Criteria solution, developed in partnership with MCG Health, enables a clinically driven revenue cycle by incorporating evidence-based admission criteria to properly determine and document bed status at the time of admission. The solution offers significant financial return for hospitals based on inappropriate bed status, determinations, and denials due to insufficient documentation.
To support both content and business development efforts, Carol Howard offers a unique blend of clinical and revenue cycle experience to add to the EvidenceCare team. As a registered nurse with extensive background in decision support, denials, utilization and revenue management, she will leverage her deep knowledge base to lead the ongoing development and support of the Admission Criteria solution.
“Emergency Departments (ED) are the front door of the hospital. They face the daunting challenge of making split-second decisions and deserve immediate access to updated medical research to ensure the best clinical outcome for patients,” said Dr. Brian Fengler, chief executive officer and co-founder of EvidenceCare. “We are thrilled to have Carol join the team and apply her front-line nursing experience and revenue cycle expertise to the launch of the Admission Criteria solution. With Carol’s leadership, we will enable frontline providers to deliver effective, efficient, and evidenced-based care.”
“Clinicians drive the revenue cycle through accurate documentation. Too often, we address denials after the fact when a proactive approach could address up to 60% of denials,” said Carol Howard, vice president, clinical content of EvidenceCare. “I am looking forward to becoming an integral part of the forward-thinkers at EvidenceCare that seek creative solutions to help hospitals remain solvent, especially given the impact of the pandemic, so that they might continue to deliver excellent care in the communities they serve.”
About EvidenceCare
EvidenceCare is the leading clinical decision support system (CDSS) driving real ROI. Founded in response to the professional experience of emergency physician Dr. Brian Fengler, the platform is integrated into a clinician’s EHR workflow, delivering customized, interactive, curated guidance directly into the care process. With EvidenceCare, hospitals, emergency departments and urgent care centers enable clinicians to deliver evidence-based care with measurable outcomes. Through advanced CDSS technology, variance is reduced, and the appropriate criteria are documented during utilization and admission decisions. With government-mandated compliance measures and quality program initiatives achieved, healthcare organizations ensure that quality and safety improve, liability is reduced, and operational efficiency is increased while capturing additional revenue. To learn more, visit http://www.evidence.care or follow us on Twitter @evidencecare or LinkedIn.
About MCG Health
MCG, part of the Hearst Health network, helps healthcare organizations implement informed care strategies that proactively and efficiently move people toward health. MCG’s transparent assessment of the latest research and scholarly articles, along with our own data analysis, gives patients, providers, and payers the vetted information they need to feel confident in every care decision, in every moment. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.
SOURCE EvidenceCare
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…